BiotechTube

Nicotine + Nicorette® (Nicotine Gum)

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
23
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Tobacco Dependence

Conditions

Tobacco Dependence

Trial Timeline

Sep 1, 2008 → Dec 1, 2008

NCT ID
NCT01113424

About Nicotine + Nicorette® (Nicotine Gum)

Nicotine + Nicorette® (Nicotine Gum) is a pre-clinical stage product being developed by Johnson & Johnson for Tobacco Dependence. The current trial status is completed. This product is registered under clinical trial identifier NCT01113424. Target conditions include Tobacco Dependence.

Hype Score Breakdown

Clinical
5
Activity
2
Company
10
Novelty
2
Community
1

Clinical Trials (1)

NCT IDPhaseStatus
NCT01113424Pre-clinicalCompleted

Competing Products

20 competing products in Tobacco Dependence

See all competitors
ProductCompanyStageHype Score
Nicotine + Nicotine + NicotineJohnson & JohnsonPre-clinical
23
Nicotine Gum + Nicotine PatchJohnson & JohnsonApproved
85
Nicotine Medicated Gum + 4 mg Nicotine Gum + 2 mg Nicotine Gum + 4 mg Nicotine LozengeJohnson & JohnsonPre-clinical
23
Nicotine + NicotineJohnson & JohnsonPre-clinical
23
Nicotine + NicotineJohnson & JohnsonPhase 1
33
Nicotine + Nicotine + NicotineJohnson & JohnsonPhase 1
33
NicotineJohnson & JohnsonPre-clinical
23
6 mg Experimental nicotine gum + 4 mg Nicotine Gum/ + 2 mg Nicotine GumJohnson & JohnsonPre-clinical
23
Nicorette Strongmint lozenge 4 mg + Niquitin MiniMint lozenge 4 mgJohnson & JohnsonPhase 1
33
Oral Nicotine + Nicotine Lozenge + Nicotine gumJohnson & JohnsonPre-clinical
23
Nicotine + Nicotine GumJohnson & JohnsonPre-clinical
23
Code STD + Code STE + Nicorette MicrotabJohnson & JohnsonPre-clinical
23
Experimental Nicotine Replacement Therapy (NRT) 2 mg + Experimental Nicotine Replacement Therapy (NRT) + Marketed Nicotine Lozenge + Marketed Nicotine LozengeJohnson & JohnsonPre-clinical
23
Nicotine + Nicotine GumJohnson & JohnsonPre-clinical
23
Nicotine Sublingual Tablet Mint (NSTM) + Marketed Nicotine TabletJohnson & JohnsonPre-clinical
23
NicotineJohnson & JohnsonPre-clinical
23
Nicotine Spray + PlaceboJohnson & JohnsonPhase 3
77
Placebo + NicotineJohnson & JohnsonPhase 3
77
Bupropion SRJohnson & JohnsonApproved
85
Nicorette Extra Mint 2 mg Gum + Nicorette Mint 2 mg Gum + Nicorette Extra Mint 4mg Gum + Nicorette Mint 4 mg GumJohnson & JohnsonPhase 1
33

Other Products from Johnson & Johnson

Fentanyl transdermal therapeutic systemApproved
85
Nicotine Gum + Nicotine PatchApproved
85
galantamineApproved
85
IbrutinibApproved
85
Paliperidone ERApproved
85